Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
| Lifeward Ltd.LFWD · Entity 7620 | Director · Chief Executive Officer | May 21, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.6103 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.5195 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.1836 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.486 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Lifeward Ltd.
Report date May 21, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | IndirectESOP | 98,728 |
Reported balance
After 2025-05-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-05-21 · Sale · Disposed 1,909 · Balance 98,728 F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person. |
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | Direct | 2,142 |
Reported balance
Holding disclosure · report date 2025-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,142 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2021 Filed Mar 4, 2021 01:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001437749-21-004907 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2022-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,500 | $51.28 | $384,567.00 |
DisclosureSEC source: 0001437749-21-004907 · rdgdoc.xml · nonDerivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.65 to $51.61. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $35.48 | $88,700.00 |
DisclosureSEC source: 0001437749-21-004907 · rdgdoc.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $23.56 | $58,900.00 |
DisclosureSEC source: 0001437749-21-004907 · rdgdoc.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $31.30 | $78,250.00 |
DisclosureSEC source: 0001437749-21-004907 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 02, 2020 Filed Dec 5, 2020 00:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-20-024899 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-12-02 F1 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 02:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-20-024489 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 02:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001437749-20-024489 · rdgdoc.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 5,000 shares Expires 2022-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 02:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,500 | $39.50 | $296,250.00 |
DisclosureSEC source: 0001437749-20-024489 · rdgdoc.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 02:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $23.56 | $58,900.00 |
DisclosureSEC source: 0001437749-20-024489 · rdgdoc.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 02:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5,000 | $31.30 | $156,500.00 |
DisclosureSEC source: 0001437749-20-024489 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 20:30 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 348 | $1.06 | $368.88 |
DisclosureSEC source: 0001178913-20-002778 · zk2024970.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,416 F1 · shares: Represents Ordinary Shares sold in the open market on October 6, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on October 5, 2020, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| June 29, 2020 Filed Jun 30, 2020 10:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 194 | $1.77 | $343.38 |
DisclosureSEC source: 0001178913-20-001894 · zk2024615.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,764 F1 · shares: Represents Ordinary Shares sold in the open market on June 29, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on June 27, 2020, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| June 18, 2020 Filed Jun 23, 2020 21:00 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001855 · zk2024592.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,958 F1 · shares: Represents 300,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 18, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| June 18, 2020 Filed Mar 16, 2021 10:03 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001045 · zk2125759.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,958 F1 · shares: Represents 300,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 18, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments starting on the first anniversary of the grant date. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 00:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-19-024833 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-12-20 F1 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| October 05, 2019 Filed Oct 8, 2019 19:57 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 469 | $2.86 | $1,341.34 |
DisclosureSEC source: 0001213900-19-019973 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: Not disclosed F1 · shares: Represents Ordinary Shares sold in the open market on June 27, 2019, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on October 5, 2019, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in three equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date F3 · valueOwnedAfter: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001437749-19-016062 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001437749-19-016062 · rdgdoc.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2020-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 5,000 | $32.00 | $160,000.00 |
DisclosureSEC source: 0001437749-19-016062 · rdgdoc.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5,000 | $14.13 | $70,650.00 |
DisclosureSEC source: 0001437749-19-016062 · rdgdoc.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $11.43 | $28,575.00 |
DisclosureSEC source: 0001437749-19-016062 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 12:32 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 105 | $4.27 | $448.36 |
DisclosureSEC source: 0001213900-19-011824 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 9,427 F1 · shares: Represents Ordinary Shares sold in the open market on June 27, 2019, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on June 27, 2019, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on June 27, 2018, the first anniversary of the date of grant, with the remaining RSUs vesting in three equal annual installments thereafter. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. F3 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| May 24, 2019 Filed May 28, 2019 19:59 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 23 | $3.03 | $69.69 |
DisclosureSEC source: 0001213900-19-009646 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 9,532 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, May 24, 2019 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. F3 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 177 | $3.66 | $647.82 |
DisclosureSEC source: 0001213900-19-007964 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 9,555 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, May 3, 2019 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. F3 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 10:42 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 310,625 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001213900-19-005013 · doc4.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,375 Underlying: Ordinary Shares, par value NIS 0.01 per share · 310,625 shares Expires 2029-03-27 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on March 27, 2019. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. F3 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 10:42 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 62,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005013 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 243,315 F1 · shares: Represents 62,125 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly installments starting on the first anniversary of the date of grant. F3 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 11:20 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 310,625 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001213900-19-005176 · doc4.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,625 Underlying: Ordinary Shares, par value NIS 0.01 per share · 310,625 shares Expires 2029-03-27 F3 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on March 27, 2019. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly instalments thereafter. F2 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 11:20 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 62,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005176 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 243,315 F1 · shares: Represents 62,125 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly installments starting on the first anniversary of the date of grant. F2 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 21:01 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 456 | $0.27 | $123.12 |
DisclosureSEC source: 0001213900-19-003088 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 181,190 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, February 22, 2019 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001209191-18-063906 · doc4.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-12-19 F1 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 11:06 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 592 | $0.21 | $124.32 |
DisclosureSEC source: 0001607962-18-000053 · wf-form4_154513119639549.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 181,646 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Saturday, December 15, 2018 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 21:01 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 392 | $0.24 | $94.08 |
DisclosureSEC source: 0001607962-18-000051 · wf-form4_154352527368845.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 182,238 F1 · shares: Represents Ordinary Shares sold in the open market on November 28, 2018, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on November 24, 2018, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter. Read SEC document |
| September 15, 2018 Filed Sep 17, 2018 12:58 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 613 | $0.94 | $576.83 |
DisclosureSEC source: 0001607962-18-000046 · wf-form4_153718909535766.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 182,630 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Saturday, September 15, 2018 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| August 24, 2018 Filed Aug 27, 2018 20:35 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 383 | $1.03 | $394.49 |
DisclosureSEC source: 0001607962-18-000044 · wf-form4_153540212520700.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 183,243 F1 · shares: Represents Ordinary Shares sold in the open market on August 27, 2018, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on August 24, 2018, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 21:29 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 1,584 | $0.99 | $1,568.16 |
DisclosureSEC source: 0001607962-18-000039 · wf-form4_153030775881507.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 183,626 F1 · shares: Represents Ordinary Shares sold in the open market on June 28, 2018, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on June 27, 2018, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on June 27, 2018, the first anniversary of the date of grant, with the remaining RSUs vesting in three equal annual installments thereafter. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 11:43 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 613 | $1.03 | $633.23 |
DisclosureSEC source: 0001607962-18-000037 · wf-form4_152932217165116.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 185,210 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, June 15, 2018 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| May 24, 2018 Filed May 31, 2018 12:32 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 423 | $1.05 | $444.15 |
DisclosureSEC source: 0001607962-18-000035 · wf-form4_152776987938475.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 185,823 F1 · shares: Represents Ordinary Shares sold in the open market on May 29, 2018, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 24, 2018, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter. Read SEC document |
| May 07, 2018 Filed May 9, 2018 20:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001209191-18-028842 · doc4.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,000 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| May 07, 2018 Filed May 9, 2018 20:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 1,000 | $34.00 | $34,000.00 |
DisclosureSEC source: 0001209191-18-028842 · doc4.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Read SEC document |
| May 07, 2018 Filed May 9, 2018 20:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,000 | $14.13 | $14,130.00 |
DisclosureSEC source: 0001209191-18-028842 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 03, 2018 Filed May 7, 2018 12:54 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 218,750 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001607962-18-000025 · wf-form4_152569763019265.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,750 Underlying: Ordinary Shares, par value NIS 0.01 per share · 218,750 shares Expires 2028-05-03 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on May 3, 2018. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| May 03, 2018 Filed May 7, 2018 12:54 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001607962-18-000025 · wf-form4_152569763019265.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 186,246 F1 · shares: Represents 43,750 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 3, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly installments starting on the first anniversary of the date of grant. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 20:06 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 613 | $1.15 | $704.95 |
DisclosureSEC source: 0001607962-18-000009 · wf-form4_152148994680155.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 142,496 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Thursday, March 15, 2018 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| February 26, 2018 Filed Feb 26, 2018 15:54 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 415 | $1.15 | $477.25 |
DisclosureSEC source: 0001607962-18-000003 · wf-form4_151966048269115.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 143,109 F1 · shares: Represents Ordinary Shares sold in the open market on February 26, 2018, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on February 24, 2018, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter. Read SEC document |
| December 22, 2017 Filed Dec 28, 2017 01:43 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001209191-17-067478 · doc4.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-12-22 F1 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 11:23 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 613 | $1.10 | $674.30 |
DisclosureSEC source: 0001628280-17-012390 · wf-form4_151359620464372.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 143,524 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, December 15, 2017 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| November 27, 2017 Filed Nov 27, 2017 21:19 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 428 | $1.15 | $492.20 |
DisclosureSEC source: 0001628280-17-011831 · wf-form4_151181753936443.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 144,137 F1 · shares: Represents Ordinary Shares sold in the open market on November 27, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on November 24, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter. Read SEC document |
| October 05, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 78,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-009768 · wf-form4_150732526459303.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 144,565 F1 · shares: Represents 78,285 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Robtics Ltd. Incentive Compensation Plan (the "2014 Plan") on October 5, 2017 as part of the equity exchange program, which commenced on September 6, 2017 and expired on October 4, 2017. The RSUs vest in three equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares. Read SEC document |
| October 04, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | Disposition to issuerOption (Right to buy) · Derivative | 100,000 | Not disclosed Strike: $8.70 | Not disclosed |
DisclosureSEC source: 0001628280-17-009768 · wf-form4_150732526459303.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares, par value NIS 0.01 per share · 100,000 shares Expires 2026-05-24 F4 · price: Represents stock options granted under the 2014 Plan on May 24, 2016. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. One-fourth of the cancelled stock options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. F4 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on May 24, 2016. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. One-fourth of the cancelled stock options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.